Physician
Lifespan of Massachusetts - Taunton INC
Lifespan of Massachusetts - Taunton INC was paid $375K by Medicaid between Oct 2024 and Dec 2024, across 81 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoLIFESPAN OF MASSACHUSETTS - TAUNTON INC
TAUNTON, MA 02780
TAUNTON, MA 02780
33aNPI1609603877assigned 09/19/2024
33bProvider typeHematology & Oncology Physician
28Total paid$375K
24GClaims7,896
24DCodes billed81
24AFirst – last monthOct 2024 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Massachusetts
Rank by total paid#2 of 25
Median peer was paid$6K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 7,896 | $375K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 465 | 443 | $86K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 326 | 316 | $67K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 288 | 281 | $66K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6.7% | 159 | 27 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.4% | 33 | 31 | $17K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.9% | 150 | 43 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 53 | 53 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 59 | 59 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 269 | 259 | $9K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 51 | 48 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 51 | 51 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 537 | 259 | $6K |
69 more codes
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 97 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 100 | $4K |
| ATP14 | 1.0% | 344 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.0% | 48 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 512 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 300 | $3K |
| 71271 | <1% | 33 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 19 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 32 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 17 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $2K |
| 97161 | <1% | 17 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 109 | $1K |
| 84484 | <1% | 214 | $1K | |
| 73562 | <1% | 31 | $823.40 | |
| 73030 | <1% | 31 | $787.60 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 33 | $775.97 |
| 83690 | <1% | 111 | $632.32 | |
| ATP08 | <1% | 66 | $599.94 | |
| 84702 | <1% | 45 | $557.34 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 86 | $541.12 |
| 81025 | <1% | 79 | $531.30 | |
| 93971 | <1% | 12 | $511.96 | |
| 87081 | <1% | 84 | $473.85 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 16 | $452.80 |
| 83880 | <1% | 17 | $450.06 | |
| 81001 | <1% | 164 | $408.80 | |
| 87807 | <1% | 35 | $392.70 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $371.28 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $371.28 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $371.28 |
| 83735 | <1% | 63 | $354.60 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 214 | $336.14 |
| 86850 | <1% | 38 | $327.56 | |
| 73630 | <1% | 15 | $322.20 | |
| 73610 | <1% | 18 | $268.50 | |
| 81003 | <1% | 136 | $247.50 | |
| 80050 | General health panel | <1% | 14 | $247.10 |
| ATP15 | <1% | 16 | $181.44 | |
| 85610 | <1% | 48 | $154.98 | |
| J2704 | Injection, propofol, 10 mg | <1% | 154 | $141.05 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $141.05 |
| 82947 | <1% | 73 | $107.57 | |
| 86901 | <1% | 41 | $105.60 | |
| 86900 | <1% | 41 | $105.60 | |
| 73130 | <1% | 12 | $89.50 | |
| 85027 | <1% | 14 | $74.23 | |
| 85007 | <1% | 14 | $43.55 | |
| 82570 | <1% | 95 | $22.85 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 76 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 94 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 87 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 401 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 51 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 34 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 55 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 108 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 161 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 15 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 176 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 38 | $0.00 |
| 80320 | 0% | 21 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 26 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 53 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 158 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 13 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 131 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGREENWOOD, EVA (SVP, FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Lifespan of Massachusetts - Fall River INC | Fall River, MA | $905K |
| The Miriam Hospital | Providence, RI | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.